Joost A. M. Verlouw
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Joost A. M. Verlouw has a total of 295 co-authors. Here are the top co-authors by number of shared publications:
- Annique Claringbould
European Molecular Biology Laboratory, Genome Biology Unit, Heidelberg, Germany
3 shared publications - Lude Franke
Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
3 shared publications - Patrick Deelen
Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
3 shared publications - Urmo Võsa
Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia
3 shared publications - Alexander Teumer
Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald, Germany
2 shared publications - Andrew Anand Brown
State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China
2 shared publications
Latest Publications
- Open Access
Trans -eQTLs reveal the architecture of human gene regulatory networks
Many non-coding variants influence complex traits and diseases through gene regulation, yet the mechanisms linking these variants to downstream biology remain poorly understood. Here, we present eQTLGen Phase 2 , a comprehensive genome-wide analysis of gene expression quantitative trait loci (eQTLs) in 43,301 blood samples from 52 datasets. Beyond local cis -effects, this sample size enabled the first systematic mapping of trans -eQTLs at scale. We identify cis -eQTLs for nearly all expressed genes (94.7%) and trans -eQTLs for over half (56.2%). Second, by colocalizing cis -eQTLs with trans -eQTLs, we infer a directed gene regulatory network comprising 47,554 directed gene regulatory relationships. These networks reveal how genetic perturbations in upstream regulators produce dose-dependent downstream effects, supported by Perturb-seq and ChIP-seq data. Third, integrating this network with 87 genome-wide association studies allows us to systematically prioritize trait-relevant pathways and candidate genes. Variants exerting both cis – and trans -effects are markedly more likely to colocalize with trait associations than cis -only variants, delineating a subset of functionally active cis -eQTLs from a large group with limited downstream impact. This distinction provides a conceptual framework for identifying regulatory variants that truly mediate complex trait biology. Together, these results provide a publicly available resource of cis – and trans -eQTLs and an in vivo scaffold for human gene-regulatory networks, elucidating how propagation of cis -effects modulates complex disease.
Open AccessTrans -eQTLs reveal the architecture of human gene regulatory networks
Many non-coding variants influence complex traits and diseases through gene regulation, yet the mechanisms linking these variants to downstream biology remain poorly understood. Here, we present eQTLGen Phase 2 , a comprehensive genome-wide analysis of gene expression quantitative trait loci (eQTLs) in 43,301 blood samples from 52 datasets. Beyond local cis -effects, this sample size enabled the first systematic mapping of trans -eQTLs at scale. We identify cis -eQTLs for nearly all expressed genes (94.7%) and trans -eQTLs for over half (56.2%). Second, by colocalizing cis -eQTLs with trans -eQTLs, we infer a directed gene regulatory network comprising 47,554 directed gene regulatory relationships. These networks reveal how genetic perturbations in upstream regulators produce dose-dependent downstream effects, supported by Perturb-seq and ChIP-seq data. Third, integrating this network with 87 genome-wide association studies allows us to systematically prioritize trait-relevant pathways and candidate genes. Variants exerting both cis – and trans -effects are markedly more likely to colocalize with trait associations than cis -only variants, delineating a subset of functionally active cis -eQTLs from a large group with limited downstream impact. This distinction provides a conceptual framework for identifying regulatory variants that truly mediate complex trait biology. Together, these results provide a publicly available resource of cis – and trans -eQTLs and an in vivo scaffold for human gene-regulatory networks, elucidating how propagation of cis -effects modulates complex disease.
- 10 December 2025
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 194 (4) , 656-666
Distinct bacterial facial cutaneous microbiota composition in adolescents with acne vulgaris: a population-based cross-sectional observational study
Background: Acne vulgaris (acne) is a prevalent dermatological condition associated with distinct facial cutaneous microbiota compositions. However, existing research often has methodological limitations such as insufficient statistical power and the under-representation of diverse adolescent populations, which are highly relevant for understanding acne pathogenesis. Objectives: To compare bacterial facial cutaneous microbiota compositions between individuals with acne and healthy control participants in a large, multiethnic adolescent population, while adjusting for potential confounders. Methods: In a population-based study, we compared bacterial facial cutaneous microbiota compositions using 16S rRNA sequencing in individuals with physician-evaluated acne (n = 399) and healthy control participants (n = 527); all included individuals were adolescents (median age 13 years). We also evaluated the independent associations of biological sex, puberty stage, perceived skin colour, ethnicity and weight with facial cutaneous microbiota compositions. Our analytical approaches included the assessment of alpha and beta diversity (including permutational multivariate analysis of variance), relative abundances, univariate coordinate analysis (analysis of compositions of microbiomes with bias correction 2) and phylogenetic analyses. Results: The overall microbiota composition of individuals with acne was less rich and less diverse than that of control participants [Chao1 β –44.98 (SE 4.36), Shannon β –1.01 (SE 0.07); P < 0.01]. While acne status was a major contributor to variations in overall microbiota compositions (R2 = 4.32%, P < 0.01), skin colour, sex, puberty stage and weight also independently contributed to variations (R2 = 0.44–1.05%; P < 0.01). Specifically, individuals with acne had higher relative abundances of Cutibacterium and Staphylococcus species, and a lower abundance of Streptococcus species. Following confounder adjustment, bias correction and phylogenetic analysis, Cutibacterium granulosum, Cutibacterium acnes and Staphylococcus epidermidis emerged as the most differentially abundant species in individuals with acne vs. control participants (log fold changes = 0.75–2.17; P < 0.01). Conclusions: Our findings reveal distinct facial microbiota compositions in adolescents with acne, identifying C. granulosum, C. acnes and S. epidermidis as a key microbial signature. This study suggests a significant clinical relevance for C. granulosum in acne pathology and a potential protective role for Streptococcus species in acne-free skin. These results underscore the importance of representative study populations in microbiome research and provide important methodological and technical insights for future investigations.
- 10 December 2025
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 194 (4) , 656-666
Distinct bacterial facial cutaneous microbiota composition in adolescents with acne vulgaris: a population-based cross-sectional observational study
Background: Acne vulgaris (acne) is a prevalent dermatological condition associated with distinct facial cutaneous microbiota compositions. However, existing research often has methodological limitations such as insufficient statistical power and the under-representation of diverse adolescent populations, which are highly relevant for understanding acne pathogenesis. Objectives: To compare bacterial facial cutaneous microbiota compositions between individuals with acne and healthy control participants in a large, multiethnic adolescent population, while adjusting for potential confounders. Methods: In a population-based study, we compared bacterial facial cutaneous microbiota compositions using 16S rRNA sequencing in individuals with physician-evaluated acne (n = 399) and healthy control participants (n = 527); all included individuals were adolescents (median age 13 years). We also evaluated the independent associations of biological sex, puberty stage, perceived skin colour, ethnicity and weight with facial cutaneous microbiota compositions. Our analytical approaches included the assessment of alpha and beta diversity (including permutational multivariate analysis of variance), relative abundances, univariate coordinate analysis (analysis of compositions of microbiomes with bias correction 2) and phylogenetic analyses. Results: The overall microbiota composition of individuals with acne was less rich and less diverse than that of control participants [Chao1 β –44.98 (SE 4.36), Shannon β –1.01 (SE 0.07); P < 0.01]. While acne status was a major contributor to variations in overall microbiota compositions (R2 = 4.32%, P < 0.01), skin colour, sex, puberty stage and weight also independently contributed to variations (R2 = 0.44–1.05%; P < 0.01). Specifically, individuals with acne had higher relative abundances of Cutibacterium and Staphylococcus species, and a lower abundance of Streptococcus species. Following confounder adjustment, bias correction and phylogenetic analysis, Cutibacterium granulosum, Cutibacterium acnes and Staphylococcus epidermidis emerged as the most differentially abundant species in individuals with acne vs. control participants (log fold changes = 0.75–2.17; P < 0.01). Conclusions: Our findings reveal distinct facial microbiota compositions in adolescents with acne, identifying C. granulosum, C. acnes and S. epidermidis as a key microbial signature. This study suggests a significant clinical relevance for C. granulosum in acne pathology and a potential protective role for Streptococcus species in acne-free skin. These results underscore the importance of representative study populations in microbiome research and provide important methodological and technical insights for future investigations.
- Open Access
- 15 September 2023
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 144 (2) , 284-295.e16
Disruption of TUFT1, a Desmosome-Associated Protein, Causes Skin Fragility, Woolly Hair, and Palmoplantar Keratoderma
- 15 September 2023
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 144 (2) , 284-295.e16
Open AccessDisruption of TUFT1, a Desmosome-Associated Protein, Causes Skin Fragility, Woolly Hair, and Palmoplantar Keratoderma
- Top Cited Papers
- 2 September 2021
- Published by Springer Nature in Nature Genetics
- Vol. 53 (9) , 1300-1310
Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression
Trait-associated genetic variants affect complex phenotypes primarily via regulatory mechanisms on the transcriptome. To investigate the genetics of gene expression, we performed cis- and trans-expression quantitative trait locus (eQTL) analyses using blood-derived expression from 31,684 individuals through the eQTLGen Consortium. We detected cis-eQTL for 88% of genes, and these were replicable in numerous tissues. Distal trans-eQTL (detected for 37% of 10,317 trait-associated variants tested) showed lower replication rates, partially due to low replication power and confounding by cell type composition. However, replication analyses in single-cell RNA-seq data prioritized intracellular trans-eQTL. Trans-eQTL exerted their effects via several mechanisms, primarily through regulation by transcription factors. Expression of 13% of the genes correlated with polygenic scores for 1,263 phenotypes, pinpointing potential drivers for those traits. In summary, this work represents a large eQTL resource, and its results serve as a starting point for in-depth interpretation of complex phenotypes.
- 2 September 2021
- Published by Springer Nature in Nature Genetics
- Vol. 53 (9) , 1300-1310
Top Cited PapersLarge-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression
Trait-associated genetic variants affect complex phenotypes primarily via regulatory mechanisms on the transcriptome. To investigate the genetics of gene expression, we performed cis- and trans-expression quantitative trait locus (eQTL) analyses using blood-derived expression from 31,684 individuals through the eQTLGen Consortium. We detected cis-eQTL for 88% of genes, and these were replicable in numerous tissues. Distal trans-eQTL (detected for 37% of 10,317 trait-associated variants tested) showed lower replication rates, partially due to low replication power and confounding by cell type composition. However, replication analyses in single-cell RNA-seq data prioritized intracellular trans-eQTL. Trans-eQTL exerted their effects via several mechanisms, primarily through regulation by transcription factors. Expression of 13% of the genes correlated with polygenic scores for 1,263 phenotypes, pinpointing potential drivers for those traits. In summary, this work represents a large eQTL resource, and its results serve as a starting point for in-depth interpretation of complex phenotypes.
- Open Access
- 18 June 2021
- Published by Springer Nature in European Journal of Human Genetics
- Vol. 29 (11) , 1611-1624
A comparison of genotyping arrays
Array technology to genotype single-nucleotide variants (SNVs) is widely used in genome-wide association studies (GWAS), clinical diagnostics, and linkage studies. Arrays have undergone a tremendous growth in both number and content over recent years making a comprehensive comparison all the more important. We have compared 28 genotyping arrays on their overall content, genome-wide coverage, imputation quality, presence of known GWAS loci, mtDNA variants and clinically relevant genes (i.e., American College of Medical Genetics (ACMG) actionable genes, pharmacogenetic genes, human leukocyte antigen (HLA) genes and SNV density). Our comparison shows that genome-wide coverage is highly correlated with the number of SNVs on the array but does not correlate with imputation quality, which is the main determinant of GWAS usability. Average imputation quality for all tested arrays was similar for European and African populations, indicating that this is not a good criterion for choosing a genotyping array. Rather, the additional content on the array, such as pharmacogenetics or HLA variants, should be the deciding factor. As the research question of a study will in large part determine which class of genes are of interest, there is not just one perfect array for all different research questions. This study can thus help as a guideline to determine which array best suits a study’s requirements.
- 18 June 2021
- Published by Springer Nature in European Journal of Human Genetics
- Vol. 29 (11) , 1611-1624
Open AccessA comparison of genotyping arrays
Array technology to genotype single-nucleotide variants (SNVs) is widely used in genome-wide association studies (GWAS), clinical diagnostics, and linkage studies. Arrays have undergone a tremendous growth in both number and content over recent years making a comprehensive comparison all the more important. We have compared 28 genotyping arrays on their overall content, genome-wide coverage, imputation quality, presence of known GWAS loci, mtDNA variants and clinically relevant genes (i.e., American College of Medical Genetics (ACMG) actionable genes, pharmacogenetic genes, human leukocyte antigen (HLA) genes and SNV density). Our comparison shows that genome-wide coverage is highly correlated with the number of SNVs on the array but does not correlate with imputation quality, which is the main determinant of GWAS usability. Average imputation quality for all tested arrays was similar for European and African populations, indicating that this is not a good criterion for choosing a genotyping array. Rather, the additional content on the array, such as pharmacogenetics or HLA variants, should be the deciding factor. As the research question of a study will in large part determine which class of genes are of interest, there is not just one perfect array for all different research questions. This study can thus help as a guideline to determine which array best suits a study’s requirements.
- Open Access
Imbalanced expression for predicted high-impact, autosomal-dominant variants in a cohort of 3,818 healthy samples
Background: One of the growing problems in genome diagnostics is the increasing number of variants that get identified through genetic testing but for which it is unknown what the significance for the disease is (Variants of Unknown Significance - VUS) 1,2 . When these variants are observed in patients, clinicians need to be able to determine their relevance for causing the patient’s disease. Here we investigated whether allele-specific expression (ASE) can be used to prioritize disease-relevant VUS and therefore assist diagnostics. In order to do so, we conducted ASE analysis in RNA-seq data from 3,818 blood samples (part of the the Dutch BIOS biobank consortium), to ascertain how VUS affect gene expression. We compared the effect of VUS variants to variants that are predicted to have a high impact, and variants that are predicted to be pathogenic but are either recessive or autosomal-dominant with low penetrance. Results: For immune and haematological disorders, we observed that 24.7% of known pathogenic variants from ClinVar show allelic imbalance in blood, as compared to 6.6% of known benign variants with matching allele frequencies. However, for other types of disorders, ASE information from blood did not distinguish (likely) pathogenic variants from benign variants. Unexpectedly, we identified 5 genes ( ALOX5, COMT, PRPF8, PSTPIP1 and SH3BP2 ) in which seven population-based samples had a predicted high impact, autosomal-dominant variant. For these genes the imbalanced expression of the major allele compensates for the lower expression of the minor allele. Conclusions: Our analysis in a large population-based gene expression cohort reveals examples of high impact, autosomal-dominant variants that are compensated for by imbalanced expression. Additionally, we observed that ASE analyses in blood are informative for predicting pathogenic variants that are associated with immune and haematological conditions. We have made all our ASE results, including many ASE calls for rare variants (MAF < 1%), available at https://molgenis15.gcc.rug.nl/ .
Open AccessImbalanced expression for predicted high-impact, autosomal-dominant variants in a cohort of 3,818 healthy samples
Background: One of the growing problems in genome diagnostics is the increasing number of variants that get identified through genetic testing but for which it is unknown what the significance for the disease is (Variants of Unknown Significance - VUS) 1,2 . When these variants are observed in patients, clinicians need to be able to determine their relevance for causing the patient’s disease. Here we investigated whether allele-specific expression (ASE) can be used to prioritize disease-relevant VUS and therefore assist diagnostics. In order to do so, we conducted ASE analysis in RNA-seq data from 3,818 blood samples (part of the the Dutch BIOS biobank consortium), to ascertain how VUS affect gene expression. We compared the effect of VUS variants to variants that are predicted to have a high impact, and variants that are predicted to be pathogenic but are either recessive or autosomal-dominant with low penetrance. Results: For immune and haematological disorders, we observed that 24.7% of known pathogenic variants from ClinVar show allelic imbalance in blood, as compared to 6.6% of known benign variants with matching allele frequencies. However, for other types of disorders, ASE information from blood did not distinguish (likely) pathogenic variants from benign variants. Unexpectedly, we identified 5 genes ( ALOX5, COMT, PRPF8, PSTPIP1 and SH3BP2 ) in which seven population-based samples had a predicted high impact, autosomal-dominant variant. For these genes the imbalanced expression of the major allele compensates for the lower expression of the minor allele. Conclusions: Our analysis in a large population-based gene expression cohort reveals examples of high impact, autosomal-dominant variants that are compensated for by imbalanced expression. Additionally, we observed that ASE analyses in blood are informative for predicting pathogenic variants that are associated with immune and haematological conditions. We have made all our ASE results, including many ASE calls for rare variants (MAF < 1%), available at https://molgenis15.gcc.rug.nl/ .
- 1 February 2020
- Published by Elsevier in Growth Hormone & IGF Research
- Vol. 50, 35-41
Unique near-complete deletion of GLI2 in a patient with combined pituitary hormone deficiency and post-axial polydactyly
- 1 February 2020
- Published by Elsevier in Growth Hormone & IGF Research
- Vol. 50, 35-41
Unique near-complete deletion of GLI2 in a patient with combined pituitary hormone deficiency and post-axial polydactyly
- Open Access
- 1 September 2018
- Published by Elsevier in Ophthalmology
- Vol. 125 (9) , 1433-1443
Whole-Exome Sequencing in Age-Related Macular Degeneration Identifies Rare Variants in COL8A1, a Component of Bruch’s Membrane
- 1 September 2018
- Published by Elsevier in Ophthalmology
- Vol. 125 (9) , 1433-1443
Open AccessWhole-Exome Sequencing in Age-Related Macular Degeneration Identifies Rare Variants in COL8A1, a Component of Bruch’s Membrane